AURKA and cancer: Because there is no evidence so far that AURKA translation is enhanced in M phase, when IRES-mediated translation is thought to be most active, IRES-dependent translational activation of AURKA could be decoupled from generic IRES-dependent mitotic translation and could exclusively be relevant as a mechanism for AURKA overexpression in cancer [134].